CAS: 61597-96-4; Isobutyl (R)-2-Hydroxypropanoate

该化合物是具有酯功能组特征的有机化合物,该化合物的特点是带有氢氧基的丙酸脊柱和分支烷基链,特别是附于第二碳的2-甲基丙基化合物组,其颜色对古黄色液体无色,具有典型的气味,通常用于各种用途,包括调味剂或其他化合物合成;该氢氧化合物组的存在有助于其在极地溶剂中的溶解性,而该酯组则影响其反应性和挥发性;该化合物可能表现出中度毒性,应在实验室环境中加以处理;其结构结构结构,特别是2R所注注的立体化学学,表明原子的具体空间安排,可能影响其生物活动和相互作用;总体而言,丙酸,2-水氧基,2-甲基异丙基酯是具有多种用途的有机化学中的重要化合物.

结构式图片

相似化合物

7699-00-5 687-47-8 585-24-0

欧盟法规

统一分类与标签REACH注册ECHA物质工作场所安全标识要求ECHA物质C&L通报REACH预注册

上下游产品

CAS号78-83-1 异丁醇 | CAS号4254-14-2 (|R|)-(-)-1,2-丙二醇 | CAS号188594-10-7 2-methylpropyl ... | CAS号103-50-4 二苄醚 | CAS号121408-94-4 (R)-(+)-isobuty... | CAS号10326-41-7 D-乳酸 | CAS号151670-13-2 (9CI)-1-[(2R)-2... | CAS号84681-87-8 1-methyl-2-(2-m... | CAS号62108-67-2 2-氯丙酸异丁酯

合成工艺路线路线简述

    9-[(R)-2-(磷酰甲氧基)丙基]腺嘌呤 反应生成 (R)-乳酸异丁酯
    参考文献:制备替诺福韦的新方法
    标题:制备替诺福韦的新方法
    摘要:本发明涉及制备替诺福韦的新方法.具体地说,本发明涉及制备抗乙肝病毒和艾滋病病毒的化合物替诺福韦特别是其一水合物的方法,该方法采用(取代)三苯基氯甲烷xiii对(R)-1,2-丙二醇的端位羟基保护,然后和磺酰氧甲基膦酸二烷基酯类v缩合得到xv,在有机酸水溶液中水解脱去xv端位羟基的保护基得中间体xi;将中间体xi的磺酸酯xii和腺嘌呤缩合得到中间体vii,然后用三甲基溴硅烷(Tmsbr)将vii转变为相应膦酸三甲基硅酯类viii,最后水解得目的物.本发明阐述的工艺路线简短,操作简便,原料价廉易得,有利于大规模生产.

    海关参考信息

    专利信息


    专利号:US-2005192265-A1
    优先权日:2003-03-20
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6849650-B2
    优先权日:1998-02-27
    标 题:Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THORSETT EUGENE D; PORTER WARREN J; NISSEN JEFFREY S; LATIMER LEE H; AUDIA JAMES E; DROSTE JAMES
    权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6399628-B1
    优先权日:1996-11-22
    标 题 :N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions comprising same, and methods for inhibiting alpha- amyloid peptide release and/or its synthesis by use of such compounds
    发明人:AUDIA JAMES E; FOLMER BEVERLY K; JOHN VARGHESE; LATIMER LEE H; NISSEN JEFFREY S; REEL JON K; THORSETT EUGENE D; WHITESITT CELIA A
    权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6495693-B2
    优先权日:1996-11-22
    标题:N-(aryl/heteroaryl) amino acid derivatives, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:AUDIA JAMES E; FOLMER BEVERLY K; JOHN VARGHESE; LATIMER LEE H; NISSEN JEFFREY S; PORTER WARREN J; THORSETT EUGENE D; WU JING
    权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
    摘要:Disclosed are compounds which inhibit beta-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:US-6906056-B2
    优先权日:1998-06-22
    标 题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:THOMPSON RICHARD C; WILKIE STEPHEN; STACK DOUGLAS R; VANMETER ELDON E; SHI QING; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; HENRY STEVEN S; MCDANIEL STACEY L; STUCKY RUSSELL D; PORTER WARREN J
    权利人:LILLY CO ELI
    摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

    专利号:EP-0951466-B1
    优先权日:1996-12-23
    标题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
    发明人:WU JING; TUNG JAY S; THORSETT EUGENE D; PLEISS MICHAEL A; NISSEN JEFFREY S; NEITZ JEFFREY; LATIMER LEE H; JOHN VARGHESE; FREEDMAN STEPHEN; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; DROSTE JAMES J; HENRY STEVEN S; MCDANIEL STACEY L; SCOTT WILLIAM L; STUCKY RUSSELL D
    权利人:ELAN PHARM INC; LILLY CO ELI
    摘要:Disclosed are compounds for Formula (I) wherein the substituents are as defined in the claims which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
    武藏野化学(中国)有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.china-musashino.com
    企业联系电话:0795-3156288👤
    📞武藏野化学(中国)有限公司 ⚠️参考联系方式
    联系人:汤女士
    电话:0795-3156288
    手机:18170558610
    传真:0795-3156287
    邮箱:sales@china-musashino.com
    通信地址: 江西省宜春经济技术开发区春风路66号
    邮编: 336000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江西省宜春经济技术开发区春风路66号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Synthetic Studies On The Bryostatins: Preparation Of A Truncated Bc-Ring Intermediate By Pyran Annulation
    作者:Gary E. Keck,Anh P. Truong |发布日期:2005.5.1
    摘要:[reaction: See Text]. A Synthesis Of A Potential Bc-Ring Subunit (C9-C27) For Bryostatin 1, A Remarkably Potent Anticancer Agent, Has Been Developed In 16 Steps And 18% Overall Yield. The Key Features Of This Route Include A Bitip-Catalyzed Asymmetric Allylation Reaction, Chelation-Controlled Allylations, A Hydroformylation Reaction, And A Pyran Annulation Reaction.

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2003).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知